a clinical study to compare two drugs, prolotherapy and steroid injection for sacroiliac joint dysfunction.
Phase 3
- Conditions
- Health Condition 1: - Health Condition 2: M259- Joint disorder, unspecified
- Registration Number
- CTRI/2024/05/067511
- Lead Sponsor
- Ruth Kikon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pain located over the Sacroiliac joint.
patients satisfying IASP diagnosing criteria of Sacroiliac joint dysfunction.
Low back pain principally below L5 vertebra.
Patient giving consent to get enrolled in study
Exclusion Criteria
Patients receiving anticoagulant therapy
Diabetic patients with HbA1C more than seven
Allergic reactions to lidocaine or suspected or diagnosed infection poor general
health, skin defects on the injection area, psychiatric problems affecting the study
Patients given prior systemic or local steroid injections within 3 months
Disorders in the hip joint.
Patient with spinal and pelvic deformity
Any infective, neoplastic pathology of spine.
Spondyloarthropathies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umeric Pain Rating scale for pain and Oswestry Disability index for disability will be assesed at 0 week (pre intervention ),visit 1 immediately (post intervention),visit 2 at 4 week, and at 6 week visit 3 post intervention for both group A and BTimepoint: Numeric Pain Rating scale for pain and Oswestry Disability index for disability will be assesed at 0 week (pre intervention ),visit 1 immediately (post intervention),visit 2 at 4 week, and at 6 week visit 3 post intervention for both group A and B
- Secondary Outcome Measures
Name Time Method To compare the functional improvement in patients with sacroiliac joint dysfunction after sacroiliac joint injection of two different agents that is prolotherapy & corticosteroid.Timepoint: 0 week,4weeks,6 weeks